1762-0193 Screening compound: 3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

1762-0193 Screening compound: 3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide
1762-0193 Screening compound: 3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 1762-0193
3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

1762-0193

Molecular Formula

C20H19ClF3N5O2 (C20 H19 ClF3 N5 O2)

Compound Name

3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

IUPAC name

3-chloro-N-[2-(morpholin-4-yl)ethyl]-5-phenyl-7-(trifluoromethyl)pyrazolo[15-a]pyrimidine-2-carboxamide

SMILES

O=C(c1nn2c(C(F)(F)F)cc(-c3ccccc3)nc2c1Cl)NCCN1CCOCC1

InChI

InChI=1S/C20H19ClF3N5O2/c21-16-17(19(30)25-6-7-28-8-10-31-11-9-28)27-29-15(20(22,23)24)12-14(26-18(16)29)13-4-2-1-3-5-13/h1-5,12H,6-11H2,(H,25,30)

InChI Key

DBNJNNIAHBQCHN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD00682612

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.85

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.143

Distribution Coefficient, logD

3.113

Water Solubility, LogSw

-4.00

Polar Surface Area

55.860

Acid Dissociation Constant (pKa)

12.54

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

35.00

1762-0193 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 1762-0193 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 1762-0193?
Check Price and Availability of 1762-0193, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 1762-0193 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 1762-0193
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 1762-0193
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 1762-0193 available by request